FDA Clearance Tracker · K243595
OviTex PRS (Long-Term Resorbable)
Last checked: Nov 19, 2026Latest source record: Dec 19, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Dec 19, 2024
Substantially Equivalent
Time to decision
29 days
Received Nov 20, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K243595
- Device name
- OviTex PRS (Long-Term Resorbable)
- Applicant
- TELA Bio, Inc.
- Applicant location
- Malvern, PA
- Received
- Nov 20, 2024
- Decided
- Dec 19, 2024
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device type
- Mesh, Surgical (FTM)
- Device class
- Class II
- Regulation
- 21 CFR 878.3300
- Specialty
- General & Plastic Surgery
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code FTM. The earliest in FDA's data is K820619, decided May 14, 1982.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K243595
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for TELA Bio, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K260474 · Decided Sep 28, 2026 · 228 days after receipt
Device type: Mesh, Surgical, Polymeric (FTL) · General & Plastic Surgery
- OviTex PRS510(k)
K241126 · Decided May 22, 2024 · 29 days after receipt
Device type: Mesh, Surgical (FTM) · General & Plastic Surgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.